US medical liability reform back in the limelight, with bill possible this week

24 January 2011

A US House Judiciary Committee, which held its first hearing, titled, "Medical Liability Reform - Cutting Costs, Spurring Investment, Creating Job," last Thursday, is focussing on ways to eliminate “frivolous” law suits against medical personnel. Chairman Lamar Smith (Republican, Texas) said he would introduce a reform bill as early as this week that would save “tens of billions every year.” Beyond that, Mr Smith said his committee would also hold hearings to tackle broader questions about the law’s constitutionality.

The Judiciary Committee is set to produce and introduce legislation that will add toward the sum total of replacing the Democrat's health care legislation, said Mr Smith on Thursday, noting: “We are waiting now, frankly, for a couple more endorsements for that bill. But as soon we get those, we could introduce the bill as soon as next week.”

System irrational and needs reforms, says AMA

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical